Blood Glucose Monitoring Device Market, [By Products (Single Point Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitters), Glucose Monitoring strips, Lancet); By End Use (Hospitals & Clinics, Diagnostic Centers, Home care Settings); By Region]: Market Size & Forecast, 2018 - 2026

Report Summary

全球血糖监测设备市场于2017年的131亿美元估价，预计预测期内的CAGR增长8.0％。血糖监测装置包括患有患有糖尿病的人经常使用的自我监测装置。在有限有限有限的国家的国家主要观察对这些设备的主要需求。这些装置包括葡萄糖仪表，通过系统准确性，即兴的技术趋势和非金属障碍提供患者健康准确信息的测试条。

全球血糖监测装置市场主要受全球各个年龄段糖尿病患病率的普遍性的推动。此外，持续的技术进步和老年老年人口的快速增长，也有助于在不久的将来促进这个市场的这一市场的增长。此外，增加需要对个体的糖水平的实时诊断，并提高对传统监测技术的连续葡萄糖监测的认识。然而，诊断技术的高成本和未能的政府监管，以增加发展中国家采用血液监测设备。

血糖监测装置市场（亿美​​元）和Y-O-Y增长（％）

Know more about this report:请求样本页面

此外，葡萄糖监测空间的创新，这些空间促进了用于消费者的便利性的使用较小的设备。此外，还改善了未来几年的促进市场增长的非侵入性技术或半侵入性技术。因此，对监测装置的创新和日益增长的需求主要在未来几年推动血糖监测设备市场增长。

细分分析

The global blood glucose monitoring device market is segmented on the basis of product type, end use and geography. Based on product type, the global blood glucose monitoring device monitoring market is segmented as Single Point Blood Glucose Meters (SBGM), Continuous Glucose Monitoring Systems (CGM), Glucose Monitoring strips, and Lancet. Continuous glucose monitoring (CGM) to be the dominating segment and is the fastest growing segment owning to increased consumer demand for CGM, and increasing number of populations suffering from type I & II diabetes globally. Additionally, user friendly CGM devices has also influenced the segments market growth during the forecast period. However, the increasing price of CGM devices and no proper reimbursement regulations by the government would impede the market growth for this segment in the coming years.

Blood Glucose Monitoring Device Market Scope

By Products	By End Use	By Region
单点血糖计 连续葡萄糖监测系统（传感器，发射器），葡萄糖监测条 Lancet	Hospitals & Clinics Diagnostic Centers 家庭护理设置	North America (U.S., Canada) Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands) Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines) Latin America (Brazil, Mexico, Argentina) 中东和非洲(阿拉伯联合酋长国、沙特阿拉伯、韩国frica)

区域分析

Geographically, the glucose monitoring device market is segmented across North America, Europe, Asia Pacific, Latin America, and Middle east & Africa. The U.S. blood glucose monitoring device market to dominate the market in terms of growing awareness in the population for the use of BGM devices. While, China is considered to the fastest growing market due to increasing healthcare spending by the citizen, and growing number of populations suffering from diabetes, increasing number of research and development for developing new BGM devices by the company, and changing life style of the population. Furthermore, China is expected to grow sale of BGM devices followed by India, Brazil, and Russia.

竞争格局

The major players operating in blood glucose monitoring device market include Abbott Laboratories, Terumo Corporation, ARKRAY Inc., Medtronic Plc., Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, Novo Nordisk A/S, Becton, Dickinson and Co., Sanofi, Bayer AG, Ypsomed AG. These leading players in the blood glucose monitoring device market are introducing innovative products in the market to cater to the consumers. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence